These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 36828243)

  • 1. In silico, in vitro and in vivo studies: Dibutyl phthalate promotes prostate cancer cell proliferation by activating Forkhead Box M1 and remission after Natura-α pretreatment.
    Bu H; Tang S; Liu G; Miao C; Zhou X; Yang H; Liu B
    Toxicology; 2023 Apr; 488():153465. PubMed ID: 36828243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natura-alpha targets forkhead box m1 and inhibits androgen-dependent and -independent prostate cancer growth and invasion.
    Li Y; Ligr M; McCarron JP; Daniels G; Zhang D; Zhao X; Ye F; Wang J; Liu X; Osman I; Mencher SK; Lepor H; Wang LG; Ferrari A; Lee P
    Clin Cancer Res; 2011 Jul; 17(13):4414-24. PubMed ID: 21606178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal exposure to Di-n-butyl phthalate (DBP) aggravate gestational diabetes mellitus via FoxM1 suppression by pSTAT1 signalling.
    Chen M; Zhao S; Guo WH; Zhu YP; Pan L; Xie ZW; Sun WL; Jiang JT
    Ecotoxicol Environ Saf; 2020 Dec; 205():111154. PubMed ID: 32810643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Prostate Cancer Subtype 1 by Forkhead Box M1 Pathway Inhibition.
    Ketola K; Munuganti RSN; Davies A; Nip KM; Bishop JL; Zoubeidi A
    Clin Cancer Res; 2017 Nov; 23(22):6923-6933. PubMed ID: 28899970
    [No Abstract]   [Full Text] [Related]  

  • 5. The estrogen receptor signaling pathway activated by phthalates is linked with transforming growth factor-β in the progression of LNCaP prostate cancer models.
    Lee HR; Hwang KA; Choi KC
    Int J Oncol; 2014 Aug; 45(2):595-602. PubMed ID: 24858230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of FOXM1 as a specific marker for triple‑negative breast cancer.
    Tan Y; Wang Q; Xie Y; Qiao X; Zhang S; Wang Y; Yang Y; Zhang B
    Int J Oncol; 2019 Jan; 54(1):87-97. PubMed ID: 30365046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baicalin suppresses the cell cycle progression and proliferation of prostate cancer cells through the CDK6/FOXM1 axis.
    Yu Z; Zhan C; Du H; Zhang L; Liang C; Zhang L
    Mol Cell Biochem; 2020 Jun; 469(1-2):169-178. PubMed ID: 32385718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXM1 promotes the progression of prostate cancer by regulating PSA gene transcription.
    Liu Y; Liu Y; Yuan B; Yin L; Peng Y; Yu X; Zhou W; Gong Z; Liu J; He L; Li X
    Oncotarget; 2017 Mar; 8(10):17027-17037. PubMed ID: 28199985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells.
    Hamurcu Z; Ashour A; Kahraman N; Ozpolat B
    Oncotarget; 2016 Mar; 7(13):16619-35. PubMed ID: 26918606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SPDEF inhibits prostate carcinogenesis by disrupting a positive feedback loop in regulation of the Foxm1 oncogene.
    Cheng XH; Black M; Ustiyan V; Le T; Fulford L; Sridharan A; Medvedovic M; Kalinichenko VV; Whitsett JA; Kalin TV
    PLoS Genet; 2014 Sep; 10(9):e1004656. PubMed ID: 25254494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis.
    Tang JH; Yang L; Chen JX; Li QR; Zhu LR; Xu QF; Huang GH; Zhang ZX; Xiang Y; Du L; Zhou Z; Lv SQ
    Cancer Commun (Lond); 2019 Dec; 39(1):81. PubMed ID: 31796105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant activation of hedgehog signaling promotes cell proliferation via the transcriptional activation of forkhead Box M1 in colorectal cancer cells.
    Wang D; Hu G; Du Y; Zhang C; Lu Q; Lv N; Luo S
    J Exp Clin Cancer Res; 2017 Feb; 36(1):23. PubMed ID: 28148279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. microRNA-877-5p exerts tumor-suppressive functions in prostate cancer through repressing transcription of forkhead box M1.
    Yang B; Diao H; Wang P; Guan F; Liu H
    Bioengineered; 2021 Dec; 12(1):9094-9102. PubMed ID: 34654353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased levels of the FoxM1 transcription factor accelerate development and progression of prostate carcinomas in both TRAMP and LADY transgenic mice.
    Kalin TV; Wang IC; Ackerson TJ; Major ML; Detrisac CJ; Kalinichenko VV; Lyubimov A; Costa RH
    Cancer Res; 2006 Feb; 66(3):1712-20. PubMed ID: 16452231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of FoxM1 by MnSOD Overexpression Contributes to Cancer Stem-Like Cell Characteristics in the Lung Cancer H460 Cell Line.
    Fu Z; Cao X; Yang Y; Song Z; Zhang J; Wang Z
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818789635. PubMed ID: 30111255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homeodomain interacting protein kinase-2 phosphorylates FOXM1 and promotes FOXM1-mediated tumor growth in renal cell carcinoma.
    Liu F; Li N; Liu Y; Zhang J; Zhang J; Wang Z
    J Cell Biochem; 2019 Jun; 120(6):10391-10401. PubMed ID: 30609136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GTSE1 promotes prostate cancer cell proliferation via the SP1/FOXM1 signaling pathway.
    Lai W; Zhu W; Li X; Han Y; Wang Y; Leng Q; Li M; Wen X
    Lab Invest; 2021 May; 101(5):554-563. PubMed ID: 33328578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexpression of CAV-1, AT1-R and FOXM1 in prostate and breast cancer and normal cell lines and their influence on metastatic properties.
    Kowalska K; Nowakowska M; Domińska K; Piastowska-Ciesielska AW
    Acta Biochim Pol; 2016; 63(3):493-9. PubMed ID: 27213551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fork head box M1 regulates vascular endothelial growth factor-A expression to promote the angiogenesis and tumor cell growth of gallbladder cancer.
    Wang RT; Miao RC; Zhang X; Yang GH; Mu YP; Zhang ZY; Qu K; Liu C
    World J Gastroenterol; 2021 Feb; 27(8):692-707. PubMed ID: 33716448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcription factor FoxM1 is the downstream target of c-Myc and contributes to the development of prostate cancer.
    Pan H; Zhu Y; Wei W; Shao S; Rui X
    World J Surg Oncol; 2018 Mar; 16(1):59. PubMed ID: 29554906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.